Skip to main content
Cantargia logo

Cantargia — Investor Relations & Filings

Ticker · CANTA ISIN · SE0023312970 LEI · 549300GKWRT7RXI4VS85 ST Manufacturing
Filings indexed 511 across all filing types
Latest filing 2018-10-20 Regulatory Filings
Country SE Sweden
Listing ST CANTA

About Cantargia

https://cantargia.com/en/

Cantargia is a biotechnology company that develops antibody-based therapies targeting the interleukin-1 receptor accessory protein (IL1RAP). This protein is involved in signaling pathways that can drive cancer and inflammatory diseases. The company's lead asset, nadunolimab (CAN04), is a clinical-stage antibody under investigation for the treatment of various forms of cancer, including pancreatic cancer. Cantargia also developed the CAN10 program, an antibody targeting IL1RAP for autoimmune and inflammatory conditions, which was acquired by Otsuka Pharmaceutical.

Recent filings

Filing Released Lang Actions
Cantargia presented positive phase I clinical data with lead candidate CAN04 at ESMO
Regulatory Filings Classification · 99% confidence The document is a press release dated October 20, 2018, announcing positive interim clinical data for the lead candidate CAN04 presented at the ESMO Congress. It details safety profiles, biomarker effects, preliminary efficacy, and next steps for the clinical trial (Phase IIa initiation). The final paragraph explicitly states: "This constitutes information that Cantargia AB is required to publish under the EU's Market Abuse Regulation." This indicates a mandatory regulatory disclosure regarding material company information that is not a standard periodic financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or SHA). Since it is a general regulatory announcement mandated by market rules and does not fit precisely into the other specific categories (like ER, CT, or IP), the most appropriate fallback category is Regulatory Filings (RNS). The document length (5548 chars) is substantial enough that it is not merely an announcement of a report (RPA), but the report/update itself.
2018-10-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.